HCV: Hierarchy-Consistency Verification for Incremental Implicitly-Refined Classification [PDF]
arXiv, 2021 Human beings learn and accumulate hierarchical knowledge over their lifetime. This knowledge is associated with previous concepts for consolidation and hierarchical construction. However, current incremental learning methods lack the ability to build a concept hierarchy by associating new concepts to old ones.
arxiv
Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.
New England Journal of Medicine, 2014 BACKGROUND The interferon-free combination of the protease inhibitor ABT-450 with ritonavir (ABT-450/r) and the NS5A inhibitor ombitasvir (also known as ABT-267) plus the nonnucleoside polymerase inhibitor dasabuvir (also known as ABT-333) and ribavirin ...
J. Feld +13 more
semanticscholar +1 more source
Model Based Framework for Estimating Mutation Rate of Hepatitis C Virus in Egypt [PDF]
arXiv, 2013 Hepatitis C virus (HCV) is a widely spread disease all over the world. HCV has very high mutation rate that makes it resistant to antibodies. Modeling HCV to identify the virus mutation process is essential to its detection and predicting its evolution.
arxiv
Global analysis of a spatiotemporal cellular model for the transmission of hepatitis C virus with Hattaf-Yousfi functional response [PDF]
arXiv, 2021 In this paper, a mathematical analysis of the global dynamics of a partial differential equation viral infection cellular model is carried out. We study the dynamics of a hepatitis C virus (HCV) model, under therapy, that considers both absorption phenomenon and diffusion of virions, infected and uninfected cells in liver. Firstly, we prove boundedness
arxiv
Designing and Development of a DNA Vaccine Based On Structural Proteins of Hepatitis C Virus [PDF]
Iranian Journal of Pathology, 2016 Background: Hepatitis C virus (HCV) infection is one of the most prevalent infectious diseases responsible for high morbidity and mortality worldwide. Therefore, designing new and effective therapeutics is of great importance.
Roghayeh Teimourpour +4 more
doaj
Liver transplantation for hepatitis C virus (HCV) non‐viremic recipients with HCV viremic donors
American Journal of Transplantation, 2018 In the context of organ shortage, the opioid epidemic, and effective direct‐acting antiviral (DAA) therapy for hepatitis C virus (HCV), more HCV‐infected donor organs may be used for liver transplantation.
A. Kwong +6 more
semanticscholar +1 more source
Sofosbuvir and ribavirin in HCV genotypes 2 and 3.
New England Journal of Medicine, 2014 BACKGROUND In clinical trials, treatment with a combination of the nucleotide polymerase inhibitor sofosbuvir and the antiviral drug ribavirin was associated with high response rates among patients with hepatitis C virus (HCV) genotype 2 infection, with ...
S. Zeuzem +16 more
semanticscholar +1 more source
Strategies to induce broadly protective antibody responses to viral glycoproteins
Expert Review of Vaccines, 2017 Introduction: Currently, several universal/broadly protective influenza virus vaccine candidates are under development. Many of these vaccines are based on strategies to induce protective antibody responses against the surface glycoproteins of ...
F Krammer
doaj +1 more source
Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan [PDF]
Clinical and Molecular HepatologyBackground/Aims Steatotic liver disease (SLD) is a common manifestation in chronic hepatitis C (CHC). Metabolic alterations in CHC are associated with metabolic dysfunction-associated steatotic liver disease (MASLD).
Chung-Feng Huang +14 more
doaj +1 more source